Panther Fusion® Flu A/B/RSV Assay
A fully-automated approach to testing of influenza A (Flu A), influenza B (Flu B) and respiratory syncytial virus (RSV) in one single assay.1
Information for Healthcare Professionals
Overview
Documents
Respiratory Testing & Patient-Specific Results
Respiratory viruses are responsible for a wide range of acute respiratory tract infections and represent a common cause of acute illness, including the common cold, influenza, and croup.1,2 Disease severity can be especially high in the young, the immunocompromised, and elderly patients.1
Increase Efficiency & Reduce Costs
Accurate and timely diagnosis of the cause of respiratory tract infections has a number of benefits for patients and their communities.
Reduces Complications
Helps reduce the potential for further development of antimicrobial resistance due to antibiotics.2,3
Patient Care First
Potential to improve patient care and helps decrease costs.2,3
Results with Purpose
Provides valued information to public health authorities regarding which viruses are circulating in the community.2,4
Reduces Spread
Assists infection control personnel to provide appropriate measures to reduce nosocomial spread.1,5
Simplify & Scale the Future of Diagnostics
The Panther Fusion Flu A/B/RSV Assay is part of the Hologic Molecular Scalable Solution, a portfolio combining a broad, high-performing assay menu with high-throughput automation. Designed to flexibly scale to meet your needs, from a single patient result to population-level screening.
Be Prepared for the Winter Respiratory Season
The Panther Fusion assay shows excellent clinical performance.1
98.8% Sensitivity
99.0% Specificity
Influenza A
100% Sensitivity
99.8% Specificity
Influenza B
99.3% Sensitivity
90.0% Specificity
RSV
Right Patient. Right Test. Right Time.6
- From true on-demand testing to high-throughput
- No sample batch constraints, prioritise urgent samples
- First results in 2.4 hours
- Run multiple assays from a single specimen tube at the same time
- Single dose, ready-to-use-assay reagent cartridge
- Long onboard stability of fluids and reagents
Verified Sample Collection
The Panther Fusion Flu A/B/RSV assay is validated for nasopharyngeal swabs in viral transport medium and universal transport medium.1
Insights
- Panther Fusion Flu A/B/RSV Assay [package insert]. AW-16162-001. San Diego, CA: Hologic, Inc.; 2022.
- Troeger C. et al GBD 2016 Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018 Nov;18(11):1191-1210. doi: 10.1016/S1473-3099(18)30310-4. Epub 2018 Sep 19. PMID: 30243584; PMCID: PMC6202443.
- Pinsky BA, Hayden RT. Cost-Effective Respiratory Virus Testing. J Clin Microbiol. 2019 Aug 26;57(9):e00373-19. doi: 10.1128/JCM.00373-19. PMID: 31142607; PMCID: PMC6711893.
- WHO-2019-nCoV-Surveillance-Guidance-2022.1-eng.pdf https://www.who.int/publications/i/item/WHO-2019-nCoV-SurveillanceGuidance-2022.2 Accessed October, 2022.
- Lim RHF, Htun HL, Li AL, Guo H, Kyaw WM, Hein AA, Ang B, Chow A. Fending off Delta - Hospital measures to reduce nosocomial transmission of COVID-19. Int J Infect Dis. 2022 Apr;117:139-145. doi: 10.1016/j.ijid.2022.01.069. Epub 2022 Feb 4. PMID: 35124240; PMCID: PMC8813202.
- Panther/Panther Fusion System Operator´s Manual. AW-26055-001 Rev 001, San Diego, CA: Hologic Inc.; 2022.
Safety Data Sheets
Package Inserts
2797
Hologic BV, Da Vincilaan 5, 1930 Zaventem, Belgium.
Notified Body number wherever applicable
EC Representative Information wherever applicable